Drugs in COVID‐19 Clinical Trials: Predicting Transporter‐Mediated Drug‐Drug Interactions Using In Vitro Assays and Real‐World Data

Numerous drugs are currently under accelerated clinical investigation for the treatment of coronavirus disease 2019 (COVID‐19); however, well‐established safety and efficacy data for these drugs are limited. The goal of this study was to predict the potential of 25 small molecule drugs in clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yee, Sook Wah, Vora, Bianca, Oskotsky, Tomiko, Zou, Ling, Jakobsen, Sebastian, Enogieru, Osatohanmwen J., Koleske, Megan L., Kosti, Idit, Rödin, Mattias, Sirota, Marina, Giacomini, Kathleen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217266/
https://www.ncbi.nlm.nih.gov/pubmed/33759449
http://dx.doi.org/10.1002/cpt.2236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217266/
https://www.ncbi.nlm.nih.gov/pubmed/33759449
http://dx.doi.org/10.1002/cpt.2236

Ejemplares similares